Plateletworks(®) as a Point-of-Care Test for ASA Non-Sensitivity

Aspirin (ASA) therapy is proven to be effective in preventing adverse cardiovascular events; however, up to 30% of patients are non-sensitive to their prescribed ASA dosage. In this pilot study, we demonstrated, for the first time, how ASA non-sensitivity can be diagnosed using Plateletworks(®), a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Hamzah, Jain, Shubha, Gallant, Reid C., Syed, Muzammil H., Zamzam, Abdelrahman, Al-Omran, Mohammed, Rand, Margaret L., Ni, Heyu, Abdin, Rawand, Qadura, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398990/
https://www.ncbi.nlm.nih.gov/pubmed/34442457
http://dx.doi.org/10.3390/jpm11080813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398990/
https://www.ncbi.nlm.nih.gov/pubmed/34442457
http://dx.doi.org/10.3390/jpm11080813

Ejemplares similares